Nasdaq
KYTX
Kyverna Therapeutics, Inc.
- Health Care
- Listed 2024
- 1 day
- +1.4%
- 1 month
- −19.9%
- 1 year
- +133%
$7.75 · Mkt cap $471M
At the 6 Aug 2026 close
Nasdaq
Kyverna Therapeutics, Inc.
$7.75 · Mkt cap $471M
At the 6 Aug 2026 close
Kyverna Therapeutics, Inc. trades under the ticker KYTX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2024. Its market capitalisation is $471M. The last closing price was $7.75, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +133%, and −19.9% over the past month. Returns are price returns and exclude dividends.
This page exists because KYTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.